Exploring the Significance of the Polypars Trial for Cardiovascular Disease Prevention

The chapter delves into the Polypars Trial in Iran, part of the Persian Cohort Study, which demonstrated a significant reduction in cardiovascular disease risk through the use of a polypill over five years with over 4,000 participants, offering valuable insights for healthcare strategies in Iran and potentially other culturally similar regions.